Learn more about the Rural Health Transformation and how states are using federal funding.

Learn more about the three waiver authorities states use most frequently: Section 1115 demonstrations, Section 1915(b) waivers, and Section 1915(c) waivers.

We’re thrilled to share that SVP Kinsey Caldwell has been named Access Innovator in the 2026 PM360 Magazine ELITE 100.

A one-day virtual event focused exclusively on the evolving Medicaid policy and drug pricing landscape. 

MFN pricing is here, expanding, and increasingly complex. CMS is advancing multiple Innovation Center models that tie U.S. drug prices to international benchmarks across Medicaid and Medicare with implications for rebates, strategy, and market access.

This year brought major disruption to Medicaid and drug pricing policy, reshaping the environment for pharmaceutical manufacturers. This recap highlights the biggest changes and lays out what to expect in 2026.